The FAS gene, brain volume, and disease progression in Alzheimer's disease
about
TRPM7 and its role in neurodegenerative diseasesMultiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosisAssociation between NME8 locus polymorphism and cognitive decline, cerebrospinal fluid and neuroimaging biomarkers in Alzheimer's disease.Neuroimaging measures as endophenotypes in Alzheimer's diseaseNeuronal apoptosis and motor deficits in mice with genetic inhibition of GSK-3 are Fas-dependentMapping the genetic variation of regional brain volumes as explained by all common SNPs from the ADNI study.Neuropathologic basis of age-associated brain atrophy.Identification of Susceptible Loci and Enriched Pathways for Bipolar II Disorder Using Genome-Wide Association Studies.Decreased cortical FADD protein is associated with clinical dementia and cognitive decline in an elderly community sample.Genetic determinants of neuronal vulnerability to apoptosis.Parent-of-origin effects of FAS and PDLIM1 in attention-deficit/hyperactivity disorderThe effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer's disease.Association of FAS and FAS ligand polymorphisms with the susceptibility and severity of lumbar disc degeneration in Chinese Han population.Interaction effects between genes involved in the AKT signaling pathway and phytoestrogens in gastric carcinogenesis: a nested case-control study from the Korean Multi-Center Cancer Cohort.Elevated Soluble Fas and FasL in Cerebrospinal Fluid and Serum of Patients With Anti-N-methyl-D-aspartate Receptor Encephalitis
P2860
Q26798376-63DE1DFB-A901-4549-A4F4-AC65CA274B0EQ28740917-6A9700A3-5F1F-4D1D-9BA7-C290D605A2C4Q34654986-39F3ACE6-4478-4A2B-BCAB-7AF5BE4E8B72Q34924165-3C2E285C-1336-482A-96FA-DABC0C4D910AQ34936432-F158B171-2738-4082-9FA0-F2FED1E70A38Q34981303-FF7AF715-7A65-48DD-B268-F2C55A48E518Q37503283-88C8B6DE-E2D3-41EF-8654-E6EF18E5F9C3Q37547264-EE7FE39F-489F-428A-915D-29814C020FA2Q37713734-2C10EB40-99A8-4F85-8DA5-7861E64C2D7CQ38018496-8DB73A96-F9C5-4B4D-B5B6-D2DC3095C974Q39959077-74742E68-30F2-4838-87A9-4935C2EEE574Q42654261-48427DFE-0EFA-464C-B17A-F78F22476DF0Q43626664-953A4B35-7C68-4334-984F-329F0339B048Q53358182-E72A8C09-BD4B-4AB6-9CCD-98D61CDFC7D0Q58556468-5C2F6322-84E7-417B-A74D-275ADD6BED76
P2860
The FAS gene, brain volume, and disease progression in Alzheimer's disease
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The FAS gene, brain volume, and disease progression in Alzheimer's disease
@ast
The FAS gene, brain volume, and disease progression in Alzheimer's disease
@en
type
label
The FAS gene, brain volume, and disease progression in Alzheimer's disease
@ast
The FAS gene, brain volume, and disease progression in Alzheimer's disease
@en
prefLabel
The FAS gene, brain volume, and disease progression in Alzheimer's disease
@ast
The FAS gene, brain volume, and disease progression in Alzheimer's disease
@en
P2093
P2860
P1476
The FAS gene, brain volume, and disease progression in Alzheimer's disease
@en
P2093
Andrew Grupe
Anne Jacobson
Deniz Erten-Lyons
Patricia Kramer
P2860
P304
P356
10.1016/J.JALZ.2009.05.663
P50
P577
2009-09-18T00:00:00Z